eXoZymes, Inc. (EXOZ) Stock

eXoZymes, Inc. (EXOZ) is a Healthcare stock trading at $7.76 (as of 2026-06-18), with a market capitalization of $81.99M and a trailing P/E of -6.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Valuation — source: SEC EDGAR (first-party)
Price	$7.76
Market Cap	$81.99M
P/E Ratio	-6.8
EV / EBITDA	-6.6
Price / Book	43.45
Price / Sales	947.50
DCF Value (model)	$-13.04
DCF Upside vs Price	-268.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$70069.00
Net Margin	-2909.1%
Return on Equity	-633.0%
Current Ratio	1.32

Valuation vs Sector & Industry
Stock P/E	-6.8
Sector P/E (Healthcare)	20.9
Industry P/E (Pharmaceutical Products)	17.0
vs Sector	-132.6%
vs Industry	-140.0%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	VANGUARD GROUP INC ($343524.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Michael Heltzen
Employees	31
Country	US
IPO Date	2024-11-13

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.